SCHEMBL23940225

SCHEMBL23940225

Cn1cc(C(=O)N2CCOCC2)c2ccccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 3/20 0.56
HDAC1 Q13547 2/20 0.56
ALDH1A1 P00352 5/20 0.55
TPSAB1 Q15661 1/20 0.54
NR4A2 P43354 1/20 0.54
POLB P06746 1/20 0.54
MAPT P10636 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
KDM4E B2RXH2 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
HPGD P15428 1/20 0.53
CYP2C19 P33261 1/20 0.53
MITF O75030 1/20 0.52
LMNA P02545 1/20 0.52
KMT2A Q03164 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
HTT P42858 1/20 0.52
DRD2 P14416 1/20 0.52
DRD3 P35462 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27249698 0.88 ALDH1A1 (0.66) HDAC6HDAC1ALDH1A1TPSAB1NR4A2
SCHEMBL3457429 0.87 ALDH1A1 (0.68) HDAC6HDAC1ALDH1A1TPSAB1NR4A2
SCHEMBL3456294 0.87 CNR1 (0.60) HDAC6HDAC1ALDH1A1TPSAB1NR4A2
SCHEMBL1558335 0.86 ALDH1A1 (0.60) ALDH1A1NR4A2POLBMAPTSMN1; SMN2
SCHEMBL27249727 0.84 HDAC6 (0.54) HDAC6HDAC1ALDH1A1TPSAB1NR4A2
SCHEMBL27249503 0.84 NR4A2 (0.47) HDAC6HDAC1ALDH1A1TPSAB1NR4A2
SCHEMBL23940212 0.83 TPSAB1 (0.60) HDAC6HDAC1ALDH1A1TPSAB1NR4A2
SCHEMBL13114473 0.82 KDM4E (0.59) ALDH1A1MAPTSMN1; SMN2KDM4ECYP1A2
SCHEMBL23940224 0.82 ALDH1A1 (0.50) HDAC6HDAC1ALDH1A1MAPTSMN1; SMN2
SCHEMBL27249754 0.82 TPSAB1 (0.62) HDAC6HDAC1TPSAB1NR4A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 US disclosed
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 US disclosed
US-20240217971-A1 PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE Université de Montréal (CA) 2024-07-04 US disclosed
US-20240217971-A1 PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE Université de Montréal (CA) 2024-07-04 US disclosed
WO-2024077391-A1 THIAZOLO[5,4-D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF UNIVERSITE DE MONTREAL (CA) 2024-04-18 WO disclosed
US-20210323966-A1 IMIDAZOPYRIDAZINE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323966-A1 IMIDAZOPYRIDAZINE COMPOUNDS TYK2, JAK3, JAK1 HDAC6 637/4885HDAC1 714/4885ALDH1A1 2637/4885
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NRAS, BRAF, KRAS HDAC6 4550/4885HDAC1 3885/4885ALDH1A1 1786/4885
US-20240217971-A1 PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS USES THEREOF FOR TREATING A PROLIFERATIVE DISEASE BRAF, NRAS, DPYD HDAC6 4473/4885HDAC1 3094/4885ALDH1A1 1619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.